Inderalici | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Inderalici
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Inderalici

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 26 USDMF, 1 CEP/COS, 2 JDMF, 5 EU WC, 9 NDC API, 22 Listed Suppliers, $ API Reference Price

51 API Suppliers
26 USDMF
1 CEP/COS
2 JDMF
5 EU WC
9 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

40 Drugs in Development

40 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

354 FDF Dossiers, 209 FDA Orange Book, 44 Europe, 17 Canada, 16 Australia, 16 South Africa, 52 Listed Dossiers

354 FDF Dossiers
209 FDA Orange Book
44 Europe
17 Canada
16 Australia
16 South Africa
52 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 160MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, CAPSULE, EXTENDED RELEASE;ORAL - 80MG, CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 80MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG
CAPSULE, EXTENDED RELEASE;ORAL - 160MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
CAPSULE, EXTENDED RELEASE;ORAL - 80MG
CAPSULE, EXTENDED RELEASE;ORAL - 120MG
CAPSULE, EXTENDED RELEASE;ORAL - 80MG

RELATED EXCIPIENT COMPANIES

5 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 11 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 25 BASF, 1 CD Formulation, 1 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 23 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 27 Roquette, 8 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 33 Thickeners and Stabilizers, 32 Granulation, 30 Direct Compression, 28 Disintegrants & Superdisintegrants, 27 Controlled & Modified Release, 26 Taste Masking, 24 Film Formers & Plasticizers, 19 Lubricants & Glidants, 14 Solubilizers, 14 Topical, 13 Co-Processed Excipients, 10 Parenteral, 9 Chewable & Orodispersible Aids, 9 Empty Capsules, 6 Emulsifying Agents, 6 Rheology Modifiers, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

64 Fillers, Diluents & Binders
53 Coating Systems & Additives
33 Thickeners and Stabilizers
32 Granulation
30 Direct Compression
28 Disintegrants & Superdisintegrants
27 Controlled & Modified Release
26 Taste Masking
24 Film Formers & Plasticizers
19 Lubricants & Glidants
14 Solubilizers
14 Topical
13 Co-Processed Excipients
10 Parenteral
9 Chewable & Orodispersible Aids
9 Empty Capsules
6 Emulsifying Agents
6 Rheology Modifiers
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
2 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 22 News #PharmaBuzz

1 Data Compilation #PharmaFlow
22 News #PharmaBuzz

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 62 Regulatory FDF Prices

18 US Medicaid Prescriptions
62 Regulatory FDF Prices

MARKET PLACE

22 APIs, 8 FDF Dossiers

22 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 2 Health Canada Patents

2 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 6 Others

2 EDQM
6 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ API Ref.Price (USD/KG) : 40 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2PIERRE FABRE DERMO-COSMETIQUE CANADA INC

filter Patent Reset all filters

2 All

01 12701953

02 12755175

filter Product Reset all filters

2 All

01 2PROPRANOLOL HYDROCHLORIDE

filter Dosage Reset all filters

2 All

01 2SOLUTION

filter Exp Date Reset all filters

2 All

01 12028-10-16

02 12030-04-12

Product Main Page

01

PIERRE FABRE DERMO-COSMETIQUE CANADA INC

Propranolol Hydrochloride

CPhI Korea

Not Confirmed

PIERRE FABRE DERMO-COSMETIQUE CANAD...

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-10-16

Date Granted : 2015-05-19

Propranolol Hydrochloride

Brand Name : HEMANGIOL

Patent Number : 2701953

Filing Date : 2008-10-16

Strength per Unit : 3.75 mg / ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-10-16

Date Granted : 2015-05-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

PIERRE FABRE DERMO-COSMETIQU...

Propranolol Hydrochloride

CPhI Korea

Not Confirmed

PIERRE FABRE DERMO-COSMETIQUE CANADA INC

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-04-12

Date Granted : 2018-01-02

Propranolol Hydrochloride

Brand Name : HEMANGIOL

Patent Number : 2755175

Filing Date : 2010-04-12

Strength per Unit : 3.75 mg / ml

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-04-12

Date Granted : 2018-01-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!